Skip to main content
Clinical Trials/CTRI/2023/04/052111
CTRI/2023/04/052111
Not yet recruiting
未知

Screening of cancer from peripheral blood sample through different stemcell-based tests

Epigeneres Biotech Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Epigeneres Biotech Pvt Ltd
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy individuals:
  • 1\. 18 years and above healthy individuals will be
  • included in the study.
  • 2\. Individuals with no prior history of cancer will be
  • Cancer patients:
  • 1\. 18 years and above cancer patients will be included
  • in the study.
  • 2\. Cancer patients will be confirmed on histopathology
  • irrespective of grade and stage.

Exclusion Criteria

  • 1\. Age less than 18 years.
  • 2\. Verified biohazard samples will be excluded.
  • 3\. Cancer subjects who have received anticancer
  • treatment within 7 days of sample collection
  • 4\. Subjects who have undergone surgery within
  • previous 2 weeks of sample collection
  • 5\. Pregnant/ lactating females
  • 6\. Subjects who have received growth factors in past 2

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With MelanomaMelanoma
NCT00588198Memorial Sloan Kettering Cancer Center754
Recruiting
Not Applicable
Detecting cancers Earlier Through Elective plasma-based CancerSEEK Testing - Ascertaining Serial Cancer patients to Enable New Diagnostic II (DETECT-ASCEND 2)single blood draw for early detect of cancerearly detection of cancer - blood test10027656
NL-OMON56411Exact Sciences Thrive LLC294
Completed
Not Applicable
Detecting cancers Earlier Through Elective plasma-based CancerSEEK Testing – Ascertaining Serial Cancer patients to Enable New Diagnostic II (DETECT-ASCEND2)breast cancer, lung cancer, colorectal cancer, prostate cancer, bladder cancer, uterine cancer, kidney/renal pelvis cancer, pancreatic cancer, liver cancer, stomach cancer, ovarian cancer, esophageal cancer, head and neck squamous cell cancer, thyroid cancer, small intestine cancer, cervical cancer, anal cancer, vulva cancer, testicular cancer
DRKS00032437Exact Sciences Thrive LLC106
Recruiting
Not Applicable
Blood-based early detection of cancer based on multiplex biomarker analysesC50C56C54Malignant neoplasm of breastMalignant neoplasm of ovaryMalignant neoplasm of corpus uteri
DRKS00016964niversitätsklinikum Heidelberg4,000
Completed
Not Applicable
Detection of Circulating tumor cells and cancer stem cells in the peripheral blood samples from digestive tract cancerEsophageal cancer, gastric cancer, gastric submucosal tumor, gastrointestinal stromal tumor, colon cancer and pancreas cancer
JPRN-UMIN000007431Digestive Disease Center, Showa University Northern Yokohama Hospital440